EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Losartan Alleviates Chemical Burn-Induced Limbal Stem Cell Deficiency: Repurposing a Venerable Anti-Hypertension Drug

Parisa Foroozandeh, Nihal Kaplan, Dan Xu, Xiaolin Qi, Elif Kayaalp-Nalbant, Stephen D Miller, Kurt Q Lu, Robert M Lavker, Han Peng

Investigative Ophthalmology & Visual Science · 15.01.2026 · 67 (1) · 35

DOI: 10.1167/iovs.67.1.35 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, erschienen am 15.01.2026. Verfasst von Parisa Foroozandeh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States. Hauptthemen laut MEDLINE: Limbal Stem Cell Deficiency, Losartan, Burns, Chemical, Antihypertensive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NCI NIH HHS, NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Currently, treatment for limbal stem cell deficiency (LSCD) involves limbal stem cell transplantation using either autologous or allogeneic tissue to restore the corneal surface. However, limitations such as donor shortages, immune rejection, and variable outcomes highlight a crucial need for more effective and safer therapeutic options.

Methods

We utilized a nitrogen mustard (NM)-induced corneal injury model to create LSCD, characterized by conjunctivalization. Mice exposed to NM were intraperitoneally injected with losartan. Single cell RNA sequencing (scRNA-seq) was conducted using a 10X Genomics platform.

Results

Previously, we demonstrated that corneal inflammation can be reversed by treatment with losartan, a widely used anti-hypertension drug with established long-term safety. Here, we demonstrate that systemic treatment with losartan markedly decreased corneal haze and inflammation during the acute and delayed phases of NM corneal injury. In the delayed phase, losartan treatment reduced NM-induced neovascularization in the cornea. Goblet cells detected within the corneal epithelium (conjunctivalization) during the delayed phase were significantly reduced following losartan treatment, indicating that losartan significantly resolves this classical hallmark of LSCD. The scRNA-seq showed that NM injury induced a dramatic increase in monocytes/macrophages in the cornea and that such an increase was attenuated by losartan treatment. Flow cytometry analysis confirmed that losartan attenuated corneal inflammation via reducing the monocytes/macrophages in the cornea.

Conclusions

Our findings strongly support a new therapeutic use for losartan in blunting LSCD, which is a consequence associated with numerous corneal inflammatory conditions (e.g. diabetic keratopathy and tear gland insufficiency).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Limbal Stem Cell DeficiencyLosartanBurns, ChemicalAntihypertensive AgentsEye BurnsLimbus CorneaeAnimalsMiceDisease Models, AnimalMice, Inbred C57BLLimbal Stem CellsMale

Substanzen

LosartanAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
  • Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.

Förderung

  • NIAMS NIH HHS
  • NCI NIH HHS
  • NEI NIH HHS
  • NIH HHS

Zitieren

APA

Foroozandeh, P., Kaplan, N., Xu, D., Qi, X., Kayaalp-Nalbant, E., Miller, S. D., Lu, K. Q., Lavker, R. M., & Peng, H. (2026). Losartan Alleviates Chemical Burn-Induced Limbal Stem Cell Deficiency: Repurposing a Venerable Anti-Hypertension Drug. Investigative Ophthalmology & Visual Science, 67(1), 35. https://doi.org/10.1167/iovs.67.1.35

Vancouver

Foroozandeh P, Kaplan N, Xu D, Qi X, Kayaalp-Nalbant E, Miller SD, et al. Losartan Alleviates Chemical Burn-Induced Limbal Stem Cell Deficiency: Repurposing a Venerable Anti-Hypertension Drug. Investigative Ophthalmology & Visual Science. 2026;67(1):35. doi:10.1167/iovs.67.1.35

BibTeX
@article{Foroozandeh2026,
  author = {Foroozandeh, Parisa and Kaplan, Nihal and Xu, Dan and Qi, Xiaolin and Kayaalp-Nalbant, Elif and Miller, Stephen D and Lu, Kurt Q and Lavker, Robert M and Peng, Han},
  title = {Losartan Alleviates Chemical Burn-Induced Limbal Stem Cell Deficiency: Repurposing a Venerable Anti-Hypertension Drug},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  volume = {67},
  number = {1},
  pages = {35},
  doi = {10.1167/iovs.67.1.35}
}
Kostenlos starten →